HAS vs RXRX · P/E 25, rev $4.75B vs rev $58.8M
Hasbro Inc (HAS) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Hasbro Inc (HAS) is a leisure company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
HAS currently screens at market cap $10.75B and trailing P/E 25.3. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the HAS and RXRX stock pages for the full models.
Not investment advice.